HU9402511D0 - A new method for quantitative assessment of p-glycoprotein-related multidrug resistance in tumor cells - Google Patents
A new method for quantitative assessment of p-glycoprotein-related multidrug resistance in tumor cellsInfo
- Publication number
- HU9402511D0 HU9402511D0 HU9402511A HU9402511A HU9402511D0 HU 9402511 D0 HU9402511 D0 HU 9402511D0 HU 9402511 A HU9402511 A HU 9402511A HU 9402511 A HU9402511 A HU 9402511A HU 9402511 D0 HU9402511 D0 HU 9402511D0
- Authority
- HU
- Hungary
- Prior art keywords
- glycoprotein
- calcein
- tumor cells
- new method
- specimen
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/80—Fluorescent dyes, e.g. rhodamine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9402511A HU217108B (hu) | 1994-08-31 | 1994-08-31 | Eljárás daganatok multidrogrezisztenciáját okozó fehérje aktivitásának in vitro mennyiségi kimutatására biológiai mintákban |
DE69510809T DE69510809T2 (de) | 1994-08-31 | 1995-08-31 | Test- und reagenziensatz für die quantitative in vitro bestimmung der aktivität von proteinen, die mehrfachresistenz gegen chemotherapeutika in tumoren verursachen, in biologischen proben |
ES95930671T ES2137538T3 (es) | 1994-08-31 | 1995-08-31 | Metodo de analisis y kit de reactivos para la determinacion cuantitativa in vitro, en muestras biologicas, de la actividad de proteinas que causan resistencia a multiples farmacos en tumores. |
EP95930671A EP0784699B1 (en) | 1994-08-31 | 1995-08-31 | Assay and reagent kit for the quantitative in vitro determination in biological specimens of the activity of proteins causing multi-drug resistance in tumors |
PCT/HU1995/000042 WO1996006945A1 (en) | 1994-08-31 | 1995-08-31 | Assay and reagent kit for the quantitative in vitro determination in biological specimens of the activity of proteins causing multi-drug resistance in tumors |
CA2198731A CA2198731C (en) | 1994-08-31 | 1995-08-31 | Assay and reagent kit for the quantitative in vitro determination in biological specimens of the activity of proteins causing multi-drug resistance in tumors |
AT95930671T ATE182179T1 (de) | 1994-08-31 | 1995-08-31 | Test- und reagenziensatz für die quantitative in vitro bestimmung der aktivität von proteinen, die mehrfachresistenz gegen chemotherapeutika in tumoren verursachen, in biologischen proben |
US08/928,528 US5872014A (en) | 1994-08-31 | 1997-09-12 | Assay for multi-drug resistance |
US09/840,791 US6391656B2 (en) | 1994-08-31 | 2001-04-23 | Assay and reagent kit for evaluation of multi-drug resistance in cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9402511A HU217108B (hu) | 1994-08-31 | 1994-08-31 | Eljárás daganatok multidrogrezisztenciáját okozó fehérje aktivitásának in vitro mennyiségi kimutatására biológiai mintákban |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9402511D0 true HU9402511D0 (en) | 1994-10-28 |
HUT72700A HUT72700A (en) | 1996-05-28 |
HU217108B HU217108B (hu) | 1999-11-29 |
Family
ID=10985550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9402511A HU217108B (hu) | 1994-08-31 | 1994-08-31 | Eljárás daganatok multidrogrezisztenciáját okozó fehérje aktivitásának in vitro mennyiségi kimutatására biológiai mintákban |
Country Status (7)
Country | Link |
---|---|
US (1) | US5872014A (hu) |
EP (1) | EP0784699B1 (hu) |
AT (1) | ATE182179T1 (hu) |
DE (1) | DE69510809T2 (hu) |
ES (1) | ES2137538T3 (hu) |
HU (1) | HU217108B (hu) |
WO (1) | WO1996006945A1 (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020042079A1 (en) * | 1994-02-01 | 2002-04-11 | Sanford M. Simon | Methods and agents for measuring and controlling multidrug resistance |
US6277655B1 (en) * | 1994-10-13 | 2001-08-21 | Solvo Biotechnology | Assay and reagent kit for evaluation of multi-drug resistance in cells |
US6162616A (en) * | 1997-04-16 | 2000-12-19 | Millennium Pharmaceuticals, Inc. | Multidrug resistance-associated polypeptide |
HUP0002557A3 (en) * | 2000-07-03 | 2004-08-30 | Solvo Biotechnologiai Kft | Simple quantitative fluorescent assay method for determining the activity of transport proteins of interest |
WO2002023186A2 (en) * | 2000-09-15 | 2002-03-21 | Virco Bvba | System and method for optimizing drug therapy for the treatment of diseases |
US20030036049A1 (en) * | 2001-01-03 | 2003-02-20 | Medis El Ltd. | Optical method for testing sensitivity of cells |
EP1448766A2 (en) * | 2001-09-27 | 2004-08-25 | University Of Delaware | Coisogenic eukaryotic cell collections |
WO2005116648A2 (en) * | 2004-05-25 | 2005-12-08 | Solvo Biotechnology, Inc. | Method and reagent kit for evaluation of multidrug-resistance activity |
US7795019B2 (en) * | 2006-11-10 | 2010-09-14 | Absorption Systems Group, Llc | Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals |
US7838256B2 (en) | 2007-02-23 | 2010-11-23 | Board Of Regents Of The University Of Nebraska | Assay and kit for drug efflux transporter activity |
US8445271B2 (en) | 2010-05-03 | 2013-05-21 | Enzo Life Sciences, Inc. | Processes and kits for determining multi-drug resistance of cells |
HU231387B1 (hu) | 2017-10-25 | 2023-06-28 | Cellpharma Kft. | Fluoreszcens festékfelhalmozódási vizsgálat |
EP3570028A1 (en) | 2018-05-15 | 2019-11-20 | MDQuest Kft. | Assessing responsiveness of rheumatoid arthritis patients to biological treatment |
HUP2100005A1 (hu) | 2018-05-15 | 2021-03-29 | Navolab Diagnosztika Kft | Rheumatoid arthrits páciensek biológiai terápiára adott válasz készségének becslése |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281061A (en) * | 1979-07-27 | 1981-07-28 | Syva Company | Double antibody for enhanced sensitivity in immunoassay |
US5407653A (en) * | 1991-06-26 | 1995-04-18 | Brigham And Women's Hospital | Evaluation of the multidrug resistance phenotype |
US5314805A (en) * | 1991-10-28 | 1994-05-24 | Molecular Probes, Inc. | Dual-fluorescence cell viability assay using ethidium homodimer and calcein AM |
-
1994
- 1994-08-31 HU HU9402511A patent/HU217108B/hu active IP Right Revival
-
1995
- 1995-08-31 DE DE69510809T patent/DE69510809T2/de not_active Expired - Lifetime
- 1995-08-31 WO PCT/HU1995/000042 patent/WO1996006945A1/en active IP Right Grant
- 1995-08-31 ES ES95930671T patent/ES2137538T3/es not_active Expired - Lifetime
- 1995-08-31 AT AT95930671T patent/ATE182179T1/de active
- 1995-08-31 EP EP95930671A patent/EP0784699B1/en not_active Expired - Lifetime
-
1997
- 1997-09-12 US US08/928,528 patent/US5872014A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE182179T1 (de) | 1999-07-15 |
DE69510809D1 (de) | 1999-08-19 |
EP0784699B1 (en) | 1999-07-14 |
HUT72700A (en) | 1996-05-28 |
DE69510809T2 (de) | 2000-03-16 |
ES2137538T3 (es) | 1999-12-16 |
HU217108B (hu) | 1999-11-29 |
EP0784699A1 (en) | 1997-07-23 |
WO1996006945A1 (en) | 1996-03-07 |
US5872014A (en) | 1999-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9402511D0 (en) | A new method for quantitative assessment of p-glycoprotein-related multidrug resistance in tumor cells | |
DE69631738D1 (de) | Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften | |
Plappert et al. | Changes in the repair capacity of blood cells as a biomarker for chronic low‐dose exposure to ionizing radiation | |
DK221090D0 (da) | Fremgangsmaade og apparat til diagnostisk analyse ved stroemmaaling | |
EP1099102A4 (en) | TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY | |
BR9508959A (pt) | "Detecção e tratamento de cancer" | |
AU5045885A (en) | Disposable sterilization biological and chemical test pack | |
HK1040533A1 (zh) | 監察蛋白脢體抑制劑藥物活動的方法 | |
AU5350290A (en) | Factor sensitive reagent for testing of blood coagulation | |
EP0277237A4 (en) | METHOD AND PROBE FOR SCREENING FOR BACTERIA IN SAMPLES. | |
EP0752872A4 (en) | NADH OXIDASE AS TARGET MOLECULE IN DIAGNOSIS AND THERAPY | |
Freilich et al. | Imipramine binding to alpha‐1‐acid glycoprotein in normal subjects and cardiac patients | |
EP0360871A4 (en) | Method for measuring biological activity of antithrombin iii and reagents for the measurement | |
FR2846426B1 (fr) | Procede de dosage du ngf pour le diagnostic in vitro du cancer du sein et utilisation en therapie | |
IT8423926A0 (it) | Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione. | |
Bohr et al. | DNA repair in lymphocytes from patients with secondary leukemia as measured by strand rejoining and unscheduled DNA synthesis | |
Hauschild | The use of serological tumor markers for malignant melanoma | |
ATE344454T1 (de) | Oxydativer stoffwechsel in glatten muskelzellen: verfahren in beziehung dazu | |
Patel et al. | Combined use of serum enzyme levels as tumor markers in cervical carcinoma patients | |
Fish et al. | Changes in serum acute phase proteins in breast cancer patients receiving methotrexate infusion therapy | |
GB8414363D0 (en) | Carrying out clinical chemical and biological testing | |
AU4518889A (en) | Method for the detection of multiple drug resistant tumor cells and verapamil probes useful therein | |
Hara et al. | A single cell gel electrophoresis technique for the detection of DNA damage induced by ACNU, an alkylating agent or irradiation in murine glioma cell lines | |
Yoshida et al. | Rapid rejoing of X-ray-induced DNA single-strand breaks in tuberous sclerosis fibroblasts | |
Nigam et al. | Some biochemical markers in various neoplasms: A multivariate analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee | ||
DNF4 | Restoration of lapsed final protection | ||
HPC4 | Succession in title of patentee |
Owner name: SOLVO BIOTECHNOLOGIAI KFT., HU |
|
GB9A | Succession in title |
Owner name: SOLVO BIOTECHNOLOGIAI ZRT., HU Free format text: FORMER OWNER(S): DR. SARKADI BALAZS, HU; DR. HOLLO ZSOLT, HU; HOMOLYA LASZLO, HU; SOLVO BIOTECHNOLOGIAI KFT., HU |
|
HC9A | Change of name, address |
Owner name: SOLVO BIOTECHNOLOGIAI ZRT., HU Free format text: FORMER OWNER(S): DR. SARKADI BALAZS, HU; DR. HOLLO ZSOLT, HU; HOMOLYA LASZLO, HU; SOLVO BIOTECHNOLOGIAI KFT., HU; SOLVO BIOTECHNOLOGIAI ZRT., HU |
|
QB4A | Exploitation contract |
Name of requester: MDQUEST KFT., HU |